Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar enuresis (92.31) Submitted: 4/7/2009 5:53:07 PM : Outperform Start Price: $17.69 ALXN Score: +357.37

eps is growing rapidly. good roe.

Featured Broker Partners


Advertisement